Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Alliance Pharma PLC

+ Add to Watchlist

DVL:GR

0.553 EUR 0.001 0.18%

As of 02:08:13 ET on 04/24/2015.

Snapshot for Alliance Pharma PLC (DVL)

Open: 0.553 Day's Range: 0.553 - 0.553 Volume: 0
Previous Close: 0.554 52wk Range: 0.358 - 0.554 1-Yr Rtn: +50.89%

Stock Chart for DVL

No chart data available.
  • DVL:GR 0.553
  • 1M
  • 1Y
0.554
Interactive DVL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DVL

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 11.6400
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2015) 0.0340
Est. PEG Ratio -
Market Cap (M EUR) 146.10
Shares Outstanding (M) 264.20
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.71%
Cash Dividend (GBp) 0.6670
Dividend Ex-Date 06/18/2015
5 Year Dividend Growth 72.19%
Next Earnings Announcement 09/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DVL

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for DVL

Alliance Pharma plc is an independent pharmaceutical company which aims to be the marketing partner of choice for emerging biotech and R&D companies. The Company acquires rights to establish brands and owns various pharmaceutical products.

John DawsonCEO/FounderRichard WrightFinance Director
Peter ButterfieldExecutive DirectorAnthony Richard Booley "Tony"Executive Director
More Company Profile & Key Executives for DVL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil